Alexamorelin Met 1 is one of the metabolites of alexamorelin. The heptapeptide Ala-His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2 (Alexamorelin) is a synthetic molecule which inhibits growth hormone secretagogue binding in vitro.
Alexamorelin Met 1 is a synthetic peptide derivative belonging to the class of growth hormone secretagogues, structurally related to the more widely studied alexamorelin. As a modified peptide fragment, it features alterations at the N-terminal methionine residue, which can influence its biochemical stability and receptor interaction profile. Researchers value this compound for its well-defined sequence and its capacity to serve as a tool in the exploration of peptide-receptor dynamics, especially in the context of growth hormone regulation. Its structural characteristics make it a relevant subject for studies investigating peptide metabolism, receptor selectivity, and the design of novel bioactive peptides.
Peptide receptor interaction studies: In the field of molecular pharmacology, Alexamorelin Met 1 is frequently used to probe the interaction between synthetic peptides and the growth hormone secretagogue receptor (GHSR). Its modified N-terminal residue provides an opportunity to assess how structural changes affect binding affinity and receptor activation. This application is essential for elucidating the molecular determinants of ligand-receptor specificity, which informs the rational design of next-generation peptide modulators with tailored biological profiles.
Peptide metabolism and stability research: The incorporation of a methionine residue at the N-terminus of this peptide fragment allows scientists to investigate the impact of specific amino acid modifications on peptide degradation pathways. By subjecting Alexamorelin Met 1 to various enzymatic and cellular environments, researchers can map the metabolic fate of modified peptides, providing valuable insights into proteolytic resistance, half-life extension strategies, and the development of more stable peptide-based research tools.
Structure-activity relationship (SAR) analysis: As a structurally defined analog of alexamorelin, this compound is instrumental in SAR studies aimed at correlating specific sequence modifications with changes in biological activity. Comparative assays using Alexamorelin Met 1 alongside related peptides enable researchers to systematically dissect the contributions of individual residues to receptor activation, efficacy, and downstream signaling. These findings underpin the iterative optimization of peptide therapeutics and research probes.
Peptide synthesis and analytical validation: Laboratories engaged in peptide chemistry utilize Alexamorelin Met 1 as a reference standard or model substrate to optimize solid-phase peptide synthesis protocols and validate analytical methods such as HPLC and mass spectrometry. Its defined sequence and physicochemical properties make it suitable for method development, quality assessment, and troubleshooting in peptide production workflows, supporting the broader field of synthetic peptide research.
Cell-based functional assays: In vitro systems employing cultured cell lines expressing GHSR or related receptors benefit from the use of this peptide fragment to stimulate, modulate, or benchmark receptor-mediated signaling pathways. By applying Alexamorelin Met 1 in controlled cellular environments, researchers can quantify receptor responsiveness, evaluate downstream signal transduction, and explore the influence of peptide modifications on functional outcomes. These studies contribute to a deeper understanding of peptide-receptor biology and the development of innovative bioassays.
2. Myotropic activity of allatostatins in tenebrionid beetles
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More